KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Other Non-Current Assets (2016 - 2025)

Exact Sciences (EXAS) has disclosed Other Non-Current Assets for 11 consecutive years, with $185.8 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 9.48% to $185.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $185.8 million through Dec 2025, up 9.48% year-over-year, with the annual reading at $185.8 million for FY2025, 9.48% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $185.8 million at Exact Sciences, up from $174.9 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $185.8 million in Q4 2025, with the low at $54.7 million in Q2 2021.
  • Average Other Non-Current Assets over 5 years is $122.0 million, with a median of $110.8 million recorded in 2022.
  • The sharpest move saw Other Non-Current Assets soared 164.37% in 2021, then dropped 25.42% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $74.6 million in 2021, then increased by 21.43% to $90.6 million in 2022, then skyrocketed by 95.84% to $177.4 million in 2023, then decreased by 4.32% to $169.7 million in 2024, then grew by 9.48% to $185.8 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $185.8 million, $174.9 million, and $124.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.